Related Experiment Video
Updated: Aug 2, 2025

10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
3.7K
Calixarene: A Supramolecular Material for Treating Cancer
1College of Pharmaceutical Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Current Drug Delivery
|April 19, 2023
Summary
Calixarene molecules are revolutionizing cancer treatment by improving drug delivery systems (DDS). These compounds enhance drug solubility and biocompatibility for better cancer therapy and diagnosis.
Area of Science:
- Supramolecular Chemistry
- Materials Science
- Oncology
Background:
- Cancer poses a significant global health challenge, necessitating innovative treatment strategies.
- Novel drug delivery systems (DDS) are crucial for enhancing therapeutic efficacy and patient outcomes.
- Calixarenes, a class of supramolecular compounds, have emerged as promising candidates for advanced DDS.
Purpose of the Study:
- To review the diverse applications of calixarene derivatives in the development of anticancer drug delivery systems.
- To explore the potential of calixarene-based DDS in clinical cancer treatment and diagnosis.
- To provide a theoretical foundation for future advancements in cancer therapy.
Main Methods:
- Literature review focusing on calixarene synthesis and modification.
- Analysis of studies detailing the incorporation of drugs with calixarene scaffolds.
- Evaluation of research on calixarene-based DDS for anticancer applications.
Main Results:
- Calixarene derivatives exhibit tunable properties, including enhanced water solubility and biocompatibility.
- Drug conjugation with calixarenes improves drug loading, stability, and targeted delivery.
- Modified calixarenes demonstrate significant potential in preclinical cancer models.
Conclusions:
- Calixarene-based DDS offer a promising platform for improving the efficacy of anticancer drugs.
- These systems hold potential for revolutionizing cancer treatment through enhanced drug delivery and diagnostics.
- Further research into calixarene applications could lead to significant breakthroughs in oncology.
Related Concept Videos
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K

